Etude de bioéquivalence entre l'inverter 4 mg et le corvasal 4 mg selon le nouveau protocole de LNCPP.

Simple item page
dc.contributor.authorBelkecir, Cherif
dc.contributor.authorAfettouche, Amar
dc.date.accessioned2019-05-14T12:09:46Z
dc.date.available2019-05-14T12:09:46Z
dc.date.issued2012
dc.description78 f. : ill. en coul. ; 30cm+(CD-ROM)en
dc.identifier.urihttps://dspace.ummto.dz/handle/ummto/2382
dc.language.isofren
dc.publisherUMMTOen
dc.subjectInverteren
dc.subjectCorvasalen
dc.subjectPharmacologieen
dc.subjectAngineen
dc.titleEtude de bioéquivalence entre l'inverter 4 mg et le corvasal 4 mg selon le nouveau protocole de LNCPP.en
dc.typeThesisen

Files

Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Belkecir, Cherif.pdf
Size:
2.66 MB
Format:
Adobe Portable Document Format
Description:
2.65 Mo
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

Département de Chimie